<DOC>
	<DOC>NCT02468206</DOC>
	<brief_summary>The purpose of this study is to study the efficacy of endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration in the prevention of gastric variceal rebleeding and improvement in survival.</brief_summary>
	<brief_title>Secondary Prophylaxis of Gastric Variceal Bleed</brief_title>
	<detailed_description />
	<mesh_term>Esophageal and Gastric Varices</mesh_term>
	<criteria>1. Cirrhosis 2. Patients who had bled from GOV2 or IGV1（≥5 days and ≤ 28days） 3. Presence of gastrorenal shunt 1. Previous treatment of gastric varices, including endoscopic therapy, NSBB, TIPS, or surgery 2. Noncirrhotic portal hypertension 3. Contraindications to cyanoacrylate injection or BRTO 4. Portal cavernoma 5. Hepatorenal syndrome 6. Proven malignancy including hepatocellular carcinoma 7. Endstage renal disease under renal replacement therapy; 8. Cardiorespiratory failure 9. Pregnancy or patients not giving informed consent for endoscopic procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>